BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that management will present at two upcoming investment conferences:
• Dr. Ryuji Ueno, Chair and Chief Executive Officer of Sucampo, will present at the BioCentury-Thomson Reuters NewsMakers in the Biotech Industry Conference, in New York, on Friday, September 7, at 1:30 pm Eastern Time.